0001127602-21-016109.txt : 20210510 0001127602-21-016109.hdr.sgml : 20210510 20210510172953 ACCESSION NUMBER: 0001127602-21-016109 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210507 FILED AS OF DATE: 20210510 DATE AS OF CHANGE: 20210510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MACKAY MARTIN CENTRAL INDEX KEY: 0001414815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 21908689 MAIL ADDRESS: STREET 1: PFIZER INC ATTN CORPORATE SECRETARY STREET 2: 235 EAST 42ND STREET CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1226 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-05-07 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL 0001414815 MACKAY MARTIN 251 BALLARDVALE STREET WILMINGTON MA 01887 1 Common Stock 2021-05-07 4 A 0 355 0 A 9380 D Common Stock 2021-05-07 4 A 0 219 0 A 9599 D Stock Options (Right to Buy) 342.55 2021-05-07 4 A 0 1151 0 A 2022-05-07 2031-05-07 Common Stock 1151 1151 D The unvested restricted stock units vest upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders. The grant was made in lieu of director service fees for the term commencing May 5, 2021. The restricted stock units vest upon the earlier of 5/7/2021, or the business day prior to the Company's next annual meeting of shareholders. The Stock Options become exercisable upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders. /s/ Martin Mackay 2021-05-10